Investigation of Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) Halted Development of its Lead Drug Candidate Robbins LLP is investigating Aligos Therapeutics, Inc. (NASDAQ: ALGS) to determine whether certain Aligos officers and directors violated securities laws